Scientists test new 'Tumor-Seeking' radiation in early cancer trial
Disease control
Ongoing
This is a very early safety study to find a safe dose of a new radioactive drug, [212Pb] VMT-alpha-NET, for people with advanced neuroendocrine tumors that have stopped responding to other treatments. The main goal is to see how much radiation the kidneys can safely handle during…
Phase: EARLY_PHASE1 • Sponsor: David Bushnell • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC